A Phase I Trial of Donor- Derived 19-28z CAR T Cells Following Allogeneic Transplant for the Treatment of CD19 Malignancies
Condition(s):Leukemia; Lymphoma; Lymphoma, B-CellLast Updated:March 18, 2022Withdrawn
Hide Studies Not Open or Pending
Condition(s):Leukemia; Lymphoma; Lymphoma, B-CellLast Updated:March 18, 2022Withdrawn
Condition(s):AML; ALL; MDS; MPD Withou Myelofibrosis; NHL or HL; Inherited Metabolic Disorders; Hemoglobinopathies; Bone Marrow Failure; HLHLast Updated:December 8, 2023Recruiting
Condition(s):BCC; BCC – Basal Cell Carcinoma; Basal Cell Carcinoma; Basal Cell Cancer; Superficial Basal Cell Carcinoma; Nodular Basal Cell CarcinomaLast Updated:May 6, 2023Active, not recruiting
Condition(s):NeuroblastomaLast Updated:June 7, 2023Recruiting
Condition(s):Papillary Thyroid Microcarcinoma; Thyroid; Thyroid CancerLast Updated:July 18, 2023Recruiting
Condition(s):Lymphoma; Refractory B-Cell Lymphoma; Lymphoma, B-Cell; DLBCL NOS; High-grade B-cell Lymphoma; Multiple MyelomaLast Updated:June 13, 2023Recruiting
Condition(s):Soft Tissue Sarcoma; Sarcoma,Soft Tissue; Sarcoma; Soft Tissue Sarcoma AdultLast Updated:September 26, 2023Recruiting
Condition(s):Cutaneous Melanocytic Neoplasm; Large Cutaneous Melanocytic Nevi; Neurocutaneous MelanocytosisLast Updated:February 13, 2024Recruiting
Condition(s):Central Nervous System/Leptomeningeal NeoplasmsLast Updated:March 21, 2024Available
Condition(s):Breast Cancer; Breast Cancer FemaleLast Updated:June 9, 2023Active, not recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.